Our clinical research is carried out with uncompromising rigor. We spare neither time nor money to achieve clear, reproducible results. Our innovative products are tested with absolute thoroughness.

Open up a new world of prevention and treatment
Our pipeline demonstrates our strengths in developing new strategies for helping to protect against flu and meningitis. We have the potential to be unique in the industry for providing a range of vaccines directed against the most prevalent meningococcal strains.

Meningococcal Disease
Broad-coverage meningococcal B vaccine
Multivalent (ACWY) meningococcal vaccine

Viral Infection
HCV vaccine in collaboration with CSL Ltd
HCV vaccine in collaboration with St. Louis University
HIV vaccine in collaboration with the NIH
Flu cell culture for influenza (EU)
Flu cell culture for influenza (U.S.)